Administration and patient-incurred costs associated with opioid agonist treatment in Norway

CONCLUSION: The analysis showed that the monthly formulation of SC-BPN was the cost-minimising alternative, followed by the weekly formulation, when considering all cost components.PMID:36172758 | DOI:10.1080/03007995.2022.2129230
Source: Current Medical Research and Opinion - Category: Research Authors: Source Type: research